Simulate the treatment of Type 1 Diabetes
The UVA/Padova T1DMS is simulation software that allows users to design and test treatment of in-silico subjects with Type 1 Diabetes Mellitus. The T1DMS improves diabetes research and product development strategies by providing control over the experimental parameters and shorter tuning cycles.

PRIMARY APPLICATIONS
-
- Simulate and test treatment protocols identical to proposed clinical studies
- Measure the impact on diabetes management and treatment
Pre-clinical experiments using the UVA/Padova T1DMS are conducted at the level of individual subjects, which provides insight into the intra- and interpersonal differences seen in humans. Real-life conditions are modeled to include varying meal sizes and timing and variable insulin dosing and timing and hyperglycemia and hypoglycemia are detected and measured.
Advantages for both industry & academic research and development
The UVA/Padova T1DMS allows the user to design experiments which examine and tune control algorithms for insulin dosing strategies and also guide and focus the emphasis of protocol designs for clinical studies.
SOFTWARE OVERVIEW |
---|
IN SILICO POPULATION
|
BASIC USER-DEFINED SIMULATION INPUT
![]() |
SUBJECT-SPECIFIC DATA TO FINE-TUNE TREATMENT
|
SIMULATION SERVICES
|
SIMULATION RESULTS DATA (PER SUBJECT AND POPULATION)
|
SIMULATION RESULTS ANALYSIS
![]() |